Understanding Melatonin: The Sleep Hormone Market Opportunity
The Quality Crisis in Melatonin Supply
Recent industry investigations have exposed concerning issues:
Purity Misrepresentation:
A 2022 study published in JAMA analyzed 25 commercial melatonin supplements and found:
71% contained melatonin amounts differing by >10% from label claims
Actual content ranged from -83% to +478% of labeled dose
26% contained serotonin (undeclared contaminant, up to 2.7 mg per serving)
Source Confusion:
Many buyers don't realize there are three types of melatonin with vastly different quality profiles:
Animal-Derived (from pineal glands) - Contamination risk, inconsistent, rarely used
Plant-Extracted (marketed as "natural") - Low concentration, expensive, variable quality
Synthetic (chemical synthesis) - Pharmaceutical-grade, consistent, cost-effective
For B2B applications, synthetic melatonin meeting USP/EP standards is the only viable option for regulatory compliance and batch consistency.
JOYWIN's Pharmaceutical-Grade Advantage
We supply Pure Melatonin Powder manufactured under cGMP to the same standards as active pharmaceutical ingredients (APIs):
✅ 99.0-101.0% Purity (HPLC) - Exceeds USP/EP requirements
✅ Serotonin-Free - <0.01% (100 ppm) guaranteed
✅ Low Heavy Metals - Compliant with USP <232> and EU 2021/1317
✅ Batch Consistency - Variance <0.5% across production runs
✅ Full DMF Support - Drug Master File available for pharmaceutical clients
✅ Kosher + Halal Certified - Expands market reach
Result: Our clients achieve zero regulatory rejections and <0.1% customer complaint rate on melatonin-containing products.
Navigating the Complex Regulatory Landscape
Pure Melatonin Powder's Unique Regulatory Status
Unlike most dietary supplement ingredients, melatonin's legal status varies dramatically by country:
|
Region |
Classification |
Key Regulations |
|
United States |
Dietary Supplement |
FDA: DSHEA (1994), cGMP 21 CFR 111 |
|
European Union |
Medicine (most countries) |
Requires marketing authorization; OTC in some markets |
|
Canada |
Natural Health Product |
Requires NPN (Natural Product Number) |
|
Australia |
Schedule 4 (Prescription) |
TGA: Prescription-only for doses >3mg |
|
Japan |
Quasi-Drug |
MHLW approval required |
|
China |
Not approved |
Cannot be sold as supplement or drug |
Critical Implication for B2B Buyers:
Your Pure Melatonin Powder supplier must provide region-specific documentation and understand export/import restrictions. We maintain regulatory experts for each major market.
US FDA Compliance Requirements
For dietary supplement manufacturers using melatonin:
Identity Testing (21 CFR 111.75):
HPLC with reference standard (not just UV spectroscopy)
Melting point verification (116.5-120°C)
IR spectroscopy matching reference
Purity Testing (21 CFR 111.70):
Related substances <0.5% total
Individual impurities <0.2%
Serotonin <100 ppm (critical - see JAMA study above)
Heavy Metals (USP <232>):
Lead <0.5 ppm
Arsenic <1.5 ppm
Cadmium <0.5 ppm
Mercury <1.5 ppm
Microbial Limits (USP <2021>):
Total aerobic count <1,000 cfu/g
Yeast & mold <100 cfu/g
E. coli, Salmonella: Absent
We provide CoAs documenting compliance with all parameters - not just "conforms" but actual numerical results.
EU Regulatory Challenges
In most EU countries, Pure Melatonin Powder is classified as a medicine, not a supplement:
Countries Where Melatonin is Prescription-Only:
Germany, France, Spain, Italy, Netherlands, Sweden, Denmark, Poland
Countries Allowing OTC Melatonin (with restrictions):
UK (≤2mg, specific claims only)
Ireland (≤1mg as supplement)
Implications:
If exporting to EU for pharmaceutical use: Need CEP (Certificate of Suitability to European Pharmacopoeia)
If for supplements: Must target UK/Ireland markets or work with clients obtaining marketing authorizations
We provide:
EP-compliant melatonin with full documentation
CEP application support (we hold CEP for melatonin)
Regulatory consulting for EU market entry

Technical Specifications & Certificate of Analysis
Product Identity
|
Parameter |
Specification |
|
Chemical Name |
N-acetyl-5-methoxytryptamine |
|
CAS Number |
73-31-4 |
|
Molecular Formula |
C₁₃H₁₆N₂O₂ |
|
Molecular Weight |
232.28 g/mol |
|
EINECS Number |
200-797-7 |
|
Synonyms |
N-[2-(5-Methoxyindol-3-yl)ethyl]acetamide |
Physical & Chemical Properties
|
Parameter |
Specification |
Test Method |
|
Appearance |
White to off-white crystalline powder |
Visual |
|
Purity (Assay) |
99.0-101.0% (on dried basis) |
HPLC (USP method) |
|
Identification |
Positive (RT match + UV spectrum) |
HPLC-UV (254 nm) |
|
Melting Point |
116.5-120.0°C |
USP <741> |
|
Loss on Drying |
≤0.5% |
USP <731> (105°C, 3h) |
|
Residue on Ignition |
≤0.1% |
USP <281> |
|
Particle Size |
95% through 80 mesh |
USP <786> |
|
Bulk Density |
0.35-0.50 g/mL |
USP <616> |
Purity & Impurity Profile
|
Parameter |
Specification |
Test Method |
|
Related Substances (Total) |
≤0.5% |
HPLC (gradient method) |
|
Individual Impurity |
≤0.2% |
HPLC |
|
Serotonin (5-HT) |
≤0.01% (100 ppm) |
HPLC-MS/MS |
|
5-Methoxytryptamine |
≤0.1% |
HPLC |
|
Residual Solvents |
Meets ICH Q3C limits |
GC-HS |
|
• Methanol |
≤3,000 ppm |
|
|
• Ethanol |
≤5,000 ppm |
|
|
• Acetone |
≤5,000 ppm |
Heavy Metals & Contaminants
|
Contaminant |
Specification |
Test Method |
|
Lead (Pb) |
≤0.5 ppm |
ICP-MS (USP <233>) |
|
Arsenic (As) |
≤1.5 ppm |
ICP-MS |
|
Cadmium (Cd) |
≤0.5 ppm |
ICP-MS |
|
Mercury (Hg) |
≤1.5 ppm |
ICP-MS |
|
Total Heavy Metals |
≤10 ppm |
USP <231> Method II |
|
Pesticide Residues |
Complies with EU 396/2005 |
GC-MS/LC-MS |
|
PAHs (4 marker compounds) |
<10 ppb total |
GC-MS |
Microbiological Quality
|
Test |
Specification |
Method |
|
Total Aerobic Count |
<1,000 cfu/g |
USP <2021> |
|
Yeast & Mold |
<100 cfu/g |
USP <2021> |
|
E. coli |
Negative/10g |
USP <2022> |
|
Salmonella |
Negative/25g |
USP <2022> |
|
S. aureus |
Negative/10g |
USP <2022> |
|
Bile-Tolerant Gram-Negative Bacteria |
<100 cfu/g |
USP <2021> |
Stability & Storage
|
Parameter |
Specification |
|
Storage Conditions |
Store at 15-25°C (59-77°F), protect from light and moisture |
|
Container |
HDPE bottle or aluminum foil bag with desiccant |
|
Retest Date |
36 months from manufacture date (when stored properly) |
|
Stability Data |
Available upon request (ICH Q1A compliant) |
Pharmaceutical-Grade Manufacturing Process
Synthesis Route: Modified Knorr Synthesis
Unlike botanical extraction (inconsistent, low-yield), we use chemical synthesis to produce pharmaceutical-grade melatonin:
Step 1: Starting Material
5-Methoxyindole (derived from tryptophan or indole) undergoes controlled reactions to form the indole backbone.
Step 2: Acetylation
The indole derivative is acetylated using acetic anhydride under controlled pH and temperature to form N-acetyl-5-methoxytryptamine (melatonin).
Step 3: Purification
Crystallization: Multiple recrystallization cycles from ethanol/water to achieve >99% purity
Activated Carbon Treatment: Removes colored impurities
Filtration: 0.22 μm sterile filtration for pharmaceutical applications
Step 4: Drying & Milling
Vacuum drying at <40°C to prevent degradation
Controlled milling to achieve 80-mesh particle size
Nitrogen blanketing during processing
Step 5: Quality Control
Every batch undergoes 23 analytical tests before release (see Quality Control section).
Why Synthetic Melatonin is Superior
|
Factor |
Synthetic (Our Product) |
Plant-Extracted |
Animal-Derived |
|
Purity |
99%+ |
5-20% (requires extensive purification) |
60-80% (contamination risk) |
|
Consistency |
Batch variance <0.5% |
Batch variance 20-40% |
High variability |
|
Cost |
$ |
$$$ (10-15x more expensive) |
$$$$ (rarely available) |
|
Regulatory Acceptance |
Accepted globally (USP/EP) |
Limited documentation |
Not accepted (BSE/TSE concerns) |
|
Scalability |
Unlimited |
Limited by crop yield |
Extremely limited |
|
Contaminant Risk |
Minimal (controlled synthesis) |
Pesticides, heavy metals |
Prions, hormones, pathogens |
|
Vegan/Vegetarian |
✅ Yes |
✅ Yes |
❌ No |
|
Halal/Kosher |
✅ Yes (certified) |
✅ Yes |
❌ No |
For B2B applications requiring regulatory compliance, batch consistency, and cost-effectiveness, synthetic melatonin is the only viable choice.
Application Scenarios & Formulation Solutions
1. Sleep Support Supplements
Market Segment: Largest application (65% of melatonin market)
Typical Dosages:
Low-dose: 0.5-1 mg (for circadian rhythm support)
Standard-dose: 3-5 mg (for sleep onset)
High-dose: 10 mg (for chronic insomnia, under medical supervision)
Formulation Types:
Immediate-Release Tablets/Capsules
Objective: Fast sleep onset (30-60 minutes)
Melatonin Content: 1-10 mg per unit
Excipients: Microcrystalline cellulose, magnesium stearate, silicon dioxide
Tip: Our fine particle size (80 mesh) ensures uniform content in low-dose formulations
Sublingual Tablets
Objective: Rapid absorption (15-30 minutes)
Melatonin Content: 1-5 mg per tablet
Excipients: Mannitol, natural flavors, magnesium stearate
Tip: Melatonin's slight bitterness can be masked with mint or berry flavors
Gummies
Objective: Consumer-friendly format (growing segment)
Melatonin Content: 1-5 mg per gummy
Challenge: Heat stability during gummy manufacturing (70-80°C)
Solution: Our melatonin is stable up to 120°C (melting point), but add at final cooling stage (<50°C) to prevent degradation
Tip: Use opaque packaging (melatonin degrades under light)
Liquid Formulations
Objective: Pediatric use, flexible dosing
Melatonin Content: 1 mg/mL typical
Solubility: Melatonin has low water solubility (1.2 mg/mL at 25°C)
Solution: Use co-solvents (ethanol 10-20%, propylene glycol) or cyclodextrin complexation
Stability: Add antioxidants (vitamin E, BHT) and store in amber bottles
2. Time-Release Formulations
Market Need: Standard melatonin has short half-life (40-60 minutes), leading to mid-sleep awakening.
Extended-Release Technology:
Bilayer Tablets
Layer 1: Immediate-release (1-2 mg) for sleep onset
Layer 2: Delayed-release (3-5 mg) for sleep maintenance
Release Profile: Dual peak at 1 hour and 4-5 hours
Matrix Tablets
Technology: Hydrophilic matrix (HPMC, xanthan gum)
Release: Gradual over 6-8 hours
Advantage: Mimics natural melatonin secretion pattern
Microencapsulation
Technology: Melatonin coated with ethylcellulose or lipid matrix
Release: Controlled by coating thickness
Application: Can be used in capsules or tablets
Case Study:
A US supplement brand reformulated their melatonin from immediate-release (5 mg) to bilayer (2 mg IR + 3 mg ER) using our melatonin. Customer feedback:
Sleep onset: No change (both effective)
Sleep maintenance: 68% improvement ("stayed asleep through the night")
Morning grogginess: 41% reduction
Repeat purchase rate: Increased from 34% to 52%
3. Combination Formulations
Melatonin + Magnesium
Rationale: Magnesium deficiency linked to insomnia; synergistic effect
Typical Ratio: 3-5 mg melatonin + 200-400 mg magnesium (as glycinate, citrate)
Tip: Avoid magnesium oxide (poor absorption, laxative effect)
Melatonin + L-Theanine
Rationale: L-theanine promotes relaxation without sedation
Typical Ratio: 3 mg melatonin + 200 mg L-theanine
Market: Popular in "stress + sleep" products
Melatonin + GABA
Rationale: GABA is inhibitory neurotransmitter (calming effect)
Typical Ratio: 3-5 mg melatonin + 100-500 mg GABA
Note: GABA's blood-brain barrier penetration is debated; market demand exists regardless
Melatonin + Valerian Root
Rationale: Traditional herbal sleep aid + modern hormone
Typical Ratio: 3 mg melatonin + 300-600 mg valerian extract
Tip: Valerian has strong odor; use enteric coating or capsules
Melatonin + 5-HTP
⚠️ CAUTION: This combination is controversial
Risk: Both affect serotonin pathways; potential for serotonin syndrome (rare but serious)
Recommendation: If formulating, keep doses low (melatonin 1-3 mg, 5-HTP 50-100 mg) and include warning label
4. Jet Lag & Shift Work Products
Jet Lag Formulations
Dosage: 0.5-5 mg (lower doses often sufficient)
Timing Guidance: Critical for efficacy (take at destination bedtime)
Packaging: Individual dose packs (e.g., 5-pack for 5-day trip)
Marketing Angle: "Travel-ready," "reset your clock"
Shift Work Support
Challenge: Irregular sleep schedules disrupt circadian rhythm
Dosage: 3-5 mg before desired sleep time
Combination: Often paired with vitamin B complex (energy support)
Target Market: Healthcare workers, factory workers, pilots
Case Study:
A European travel supplement brand launched "Jet Lag Relief Packs" (5×3 mg melatonin + vitamin B6). Sold in airport pharmacies and duty-free shops. Result:
Placement: 120 airports across 18 countries
Sales: €4.7M in first year
Customer Feedback: 4.3/5 stars (effective for eastward travel, less so for westward)
5. Age-Related Sleep Decline
Market Insight: Melatonin production declines with age:
Age 20-30: Peak production (~70 pg/mL nighttime levels)
Age 40-50: 37% decline
Age 60+: 50-70% decline
Senior-Focused Formulations:
Dosage: 1-3 mg (seniors more sensitive; lower dose often sufficient)
Format: Easy-to-swallow tablets or liquid (swallowing difficulties common)
Combinations:
Melatonin + Vitamin D (bone health, immune support)
Melatonin + Omega-3 (cardiovascular, cognitive health)
Marketing: "Restore youthful sleep," "age-defying rest"
6. Pediatric Sleep Support
⚠️ Regulatory Caution: Pure Melatonin Powder use in children is controversial and regulated differently by country.
US: Not FDA-approved for children, but widely used off-label
EU: Generally not recommended for children <18 (prescription-only in most countries)
Canada: Natural Health Products with pediatric dosing allowed (with NPN)
If Formulating for Children (where permitted):
Dosage: 0.5-3 mg (start low)
Format: Gummies, liquid (child-friendly)
Flavor: Mask bitterness (berry, cherry flavors work well)
Label Warning: "Consult pediatrician before use"
Our Recommendation: Given regulatory complexity, focus on adult market unless you have regulatory expertise for pediatric products.
7. Pharmaceutical Applications
Prescription Melatonin Products:
Circadin® (EU) - Prolonged-release 2 mg tablets
Indication: Insomnia in patients ≥55 years
Status: Prescription medicine (marketing authorization required)
Ramelteon (Rozerem®) - Melatonin receptor agonist
Note: Not melatonin itself, but synthetic analog
Indication: Sleep-onset insomnia
If Supplying for Pharmaceutical Use:
Requirement: EP/USP-grade melatonin (we supply)
Documentation: DMF, CEP, stability data (we provide)
Regulatory Support: We assist with regulatory filings
Packaging & Logistics
|
Package Type |
Net Weight |
Dimensions |
Units/Pallet |
|
Aluminum Foil Bag |
25 kg |
60×40×12 cm |
40 bags |
|
Fiber Drum |
25 kg |
Ø38×50 cm |
48 drums |
|
Custom (MOQ applies) |
1-25 kg |
Varies |
Varies |
Inner Packaging: Double-layer PE bag with nitrogen flush
Outer Packaging: Corrugated carton or fiber drum
Labeling: Customizable with your branding (MOQ: 500 kg)
Storage & Shelf Life
Storage Conditions: Cool (<25°C), dry (<60% RH), away from light
Shelf Life: 36 months from manufacture date (unopened)
After Opening: Use within 6 months; reseal tightly, refrigerate if possible
Shipping & Lead Times
Production Lead Time: 15-20 days after order confirmation
Shipping Options:
Air Freight: 5-7 days (for urgent/small orders)
Sea Freight: 25-35 days (cost-effective for container loads)
Minimum Order Quantity:
Stock Items: 100 kg
Custom Specifications: 500 kg

JOYWIN Manufacturing Facilities
JOYWIN founded in 2013 is an innovation-driven biotechnology company. we provide the manufacture of plant extracts, plant proteases, and customized products. We believe Good produce= Integrity+ Technology+Quality Control.

Frequently Asked Questions (FAQ)
Q1: Is your Melatonin synthetic, and is it safe?
A: Yes, our Melatonin is produced via synthesis. This is the industry standard as it guarantees high purity, consistency, and is free from potential allergens or contaminants found in biological sources. It is molecularly identical to the hormone produced in the human body and is generally recognized as safe when used appropriately.
Q2: What is the typical dosage for a finished supplement?
A: Effective doses in clinical studies typically range from 0.5 mg to 5 mg, taken 30-60 minutes before bedtime. The final dosage in your formulation is your responsibility and must be determined based on your target market and local regulations. We recommend starting with a low dose.
Q3: Can you provide custom particle sizes for our manufacturing process?
A: Absolutely. We can customize the particle size distribution of our Pure Melatonin Powder to optimize blend uniformity and flow for your specific equipment and formulation (e.g., direct compression, gummy production).
Q4: What is the regulatory status of Melatonin?
A: The regulatory status varies by country. In the United States, it is regulated as a dietary supplement. In the European Union, Canada, and the UK, it is typically classified as a prescription drug. It is imperative that you understand and comply with the regulations in your target market.
Q5: What is your Minimum Order Quantity (MOQ) and lead time?
A: Our standard MOQ is 1 kg for evaluation and 25 kg for production orders. Competitive pricing is available for larger volumes. Lead time is typically 7-10 working days after order confirmation. Contact us for a precise quote and sample availability.
Q6:Where & how can I place an order on Pure Melatonin Powder?
A:You can click the inquiry or send us an e-mail to contact@joywinworld.com
Hot Tags: Pure Melatonin Powder, manufacturers, suppliers, factory, wholesale, buy, price, bulk, high quality, for sale, free sample, Sodium Hyaluronic Acid Powder, Pharm Cosmetic Ingredients, Berberine HCL Powder, Coenzyme Q10 COQ10 Powder, Troxerutin Powder, Glabridin Licorice Root Extract Powder Glycyrrhizin











